RE:Bloom Burton and Co. comments on ProMetic Life Sciences Inc.It's interesting how they "forgot" to mention the Diabetic Foot Ulcer trial likely to start shortly, along with the already positive reulss OMNIO/Prometic have already achieved in that regard, along with the 500,000-2 million patients in North America alone for that indication.
Funny how that is, don't you think?